Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone Treatment in SGA Children
NCT00184756Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Nov 2002
- Primary completion
- Jul 2006
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 8
01
Overview
Phase 3, randomised, double-blind trial in Small for gestational age (SGA) comparing Somatropin with Placebo/Control (2 arms). Primary endpoint: Height at 2 years. Started Nov 2002; status: completed.
02
Drugs
somatropin
03
Conditions
Small for gestational age (SGA)
Beyond the preview
Go deeper on NCT00184756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00184756.